Kalbe Farma Prepares Buyback Shares Worth IDR 250 Billion

JAKARTA - PT Kalbe Farma Tbk (KLBF) plans to buy back shares (buyback) with a maximum value of IDR 250 billion.

In an information disclosure, Kalbe said that the buyback period will take place from September 4 to December 3, 2025 and transactions will be carried out through the IDX using securities brokerage services.

The cost of implementing the buyback will be limited to transaction fees and intermediary services, with a maximum limit of 0.1 percent of the total purchase value.

Meanwhile, the funds for the buyback are entirely sourced from the company's internal cash.

Kalbe's management estimates that this action will only have a small impact on interest income, which is reduced by around Rp. 2.5 billion after the buyback program ends and this decline is considered not to have a significant impact on the company's overall financial condition.

Based on performance calculations taking into account the decline in revenue and the number of shares purchased again, profit per share is estimated to increase to IDR 70.43, higher than profit per share as of December 31, 2024, which was recorded at IDR 70.16.

- https://voi.id/ekonomi/511652/bappenas-dapat-pagu-anggaran-rp2-59-triliun-di-2026-mayoritas-untuk-gaji-pegawai

- https://voi.id/ekonomi/511641/kkp-usulkan-dana-alokasi-khusus-bidang-pangan-akuatik-rp1-29-triliun-pada-2026

- https://voi.id/ekonomi/511637/anggaran-kkp-tahun-depan-naik-signifikan-jadi-rp13-triliun-buat-apa-saja

[/see_also]

Kalbe's management hopes that the buyback carried out can give investors confidence in the company's share value fundamentally.

"The buyback of the company's shares also provides flexibility for the Company in managing long-term capital, where treasury shares can be diverted in the future with an optimal value to increase value for shareholders," quoted Wednesday, September 3.